Ginkgo Bioworks Holdings (DNA) Return on Assets (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Return on Assets of 0.0% for Q1 2026, down 6.73% on a QoQ basis from 0.0% in Q4 2025, and little changed year-over-year from 0.0% in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Return on Assets (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Return on Assets history runs 6 years deep, the most recent figure standing at 0.0% for Q1 2026.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Assets was 0.0% for Q1 2026 at Ginkgo Bioworks Holdings, down from 0.0% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q2 2025 and bottomed at 0.02% in Q3 2022.
- A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2022 — Return on Assets slipped 2 bps — and 2023, when it grew 1 bps.
- Ginkgo Bioworks Holdings' Return on Assets stood at 0.01% in 2022, then jumped by 49 bps to 0.0% in 2023, then advanced by 21 bps to 0.0% in 2024, then surged by 48 bps to 0.0% in 2025, then retreated by 7 bps to 0.0% in 2026.
- Business Quant data shows DNA's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.01% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -0.80% |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 0.00% |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |